Taiwan · Delayed Price · Currency is TWD HeXun Biosciences Statistics
Total Valuation
TPEX:6986 has a market cap or net worth of TWD 2.97 billion. The enterprise value is 2.58 billion.
| Market Cap | 2.97B |
| Enterprise Value | 2.58B |
Important Dates
The next estimated earnings date is Thursday, November 13, 2025.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:6986 has 46.00 million shares outstanding. The number of shares has increased by 0.16% in one year.
| Current Share Class | 46.00M |
| Shares Outstanding | 46.00M |
| Shares Change (YoY) | +0.16% |
| Shares Change (QoQ) | +0.15% |
| Owned by Insiders (%) | 32.17% |
| Owned by Institutions (%) | n/a |
| Float | 24.40M |
Valuation Ratios
The trailing PE ratio is 22.67.
| PE Ratio | 22.67 |
| Forward PE | n/a |
| PS Ratio | 9.76 |
| PB Ratio | 4.33 |
| P/TBV Ratio | 4.48 |
| P/FCF Ratio | 19.50 |
| P/OCF Ratio | 16.94 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.42, with an EV/FCF ratio of 16.90.
| EV / Earnings | 19.62 |
| EV / Sales | 8.46 |
| EV / EBITDA | 14.42 |
| EV / EBIT | 16.86 |
| EV / FCF | 16.90 |
Financial Position
The company has a current ratio of 8.26, with a Debt / Equity ratio of 0.05.
| Current Ratio | 8.26 |
| Quick Ratio | 7.80 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.19 |
| Debt / FCF | 0.22 |
| Interest Coverage | 141.34 |
Financial Efficiency
Return on equity (ROE) is 21.24% and return on invested capital (ROIC) is 14.64%.
| Return on Equity (ROE) | 21.24% |
| Return on Assets (ROA) | 13.66% |
| Return on Invested Capital (ROIC) | 14.64% |
| Return on Capital Employed (ROCE) | 21.32% |
| Revenue Per Employee | 6.77M |
| Profits Per Employee | 2.92M |
| Employee Count | 45 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 2.30 |
Taxes
In the past 12 months, TPEX:6986 has paid 23.76 million in taxes.
| Income Tax | 23.76M |
| Effective Tax Rate | 15.32% |
Stock Price Statistics
The stock price has decreased by -17.71% in the last 52 weeks. The beta is 0.13, so TPEX:6986's price volatility has been lower than the market average.
| Beta (5Y) | 0.13 |
| 52-Week Price Change | -17.71% |
| 50-Day Moving Average | 68.00 |
| 200-Day Moving Average | 72.65 |
| Relative Strength Index (RSI) | 39.46 |
| Average Volume (20 Days) | 104,962 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6986 had revenue of TWD 304.45 million and earned 131.32 million in profits. Earnings per share was 2.85.
| Revenue | 304.45M |
| Gross Profit | 277.60M |
| Operating Income | 152.79M |
| Pretax Income | 155.08M |
| Net Income | 131.32M |
| EBITDA | 175.26M |
| EBIT | 152.79M |
| Earnings Per Share (EPS) | 2.85 |
Balance Sheet
The company has 429.74 million in cash and 34.12 million in debt, giving a net cash position of 395.62 million or 8.60 per share.
| Cash & Cash Equivalents | 429.74M |
| Total Debt | 34.12M |
| Net Cash | 395.62M |
| Net Cash Per Share | 8.60 |
| Equity (Book Value) | 686.02M |
| Book Value Per Share | 14.87 |
| Working Capital | 496.33M |
Cash Flow
In the last 12 months, operating cash flow was 175.46 million and capital expenditures -23.04 million, giving a free cash flow of 152.42 million.
| Operating Cash Flow | 175.46M |
| Capital Expenditures | -23.04M |
| Free Cash Flow | 152.42M |
| FCF Per Share | 3.31 |
Margins
Gross margin is 91.18%, with operating and profit margins of 50.18% and 43.13%.
| Gross Margin | 91.18% |
| Operating Margin | 50.18% |
| Pretax Margin | 50.94% |
| Profit Margin | 43.13% |
| EBITDA Margin | 57.57% |
| EBIT Margin | 50.18% |
| FCF Margin | 50.07% |
Dividends & Yields
TPEX:6986 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.16% |
| Shareholder Yield | n/a |
| Earnings Yield | 4.42% |
| FCF Yield | 5.13% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |